Curcumin and Alzheimer's disease
T Hamaguchi, K Ono, M Yamada - CNS neuroscience & …, 2010 - Wiley Online Library
Curcumin has a long history of use as a traditional remedy and food in Asia. Many studies
have reported that curcumin has various beneficial properties, such as antioxidant, …
have reported that curcumin has various beneficial properties, such as antioxidant, …
[HTML][HTML] Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer's disease
… Recently, we used fluorescence spectroscopy with thioflavin T (ThT) and electron
microscopy (EM) to examine the effects of wine-related polyphenols, myricetin (Myr), morin (Mor), …
microscopy (EM) to examine the effects of wine-related polyphenols, myricetin (Myr), morin (Mor), …
[HTML][HTML] Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
…, K Muro, Y Saito, Y Ito, Y Ajioka, T Hamaguchi… - International journal of …, 2020 - Springer
The number of deaths from colorectal cancer in Japan continues to increase. Colorectal
cancer deaths exceeded 50,000 in 2016. In the 2019 edition, revision of all aspects of …
cancer deaths exceeded 50,000 in 2016. In the 2019 edition, revision of all aspects of …
Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease
T Hamaguchi, T Kitamoto, T Sato, H Mizusawa… - Neurology, 2005 - AAN Enterprises
Background: No method for the clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob
disease (sCJD) has been established except for pathologic examination. Objective: To identify …
disease (sCJD) has been established except for pathologic examination. Objective: To identify …
[HTML][HTML] Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin
Y Matsumura, T Hamaguchi, T Ura, K Muro… - British journal of …, 2004 - nature.com
NK911 is a novel supramolecular nanocarrier designed for the enhanced delivery of
doxorubicin (DXR) and is one of the successful polymer micelle systems to exhibit an efficient …
doxorubicin (DXR) and is one of the successful polymer micelle systems to exhibit an efficient …
[HTML][HTML] Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
…, Y Hashiguchi, Y Ito, Y Saito, T Hamaguchi… - International journal of …, 2018 - Springer
Japanese mortality due to colorectal cancer is on the rise, surpassing 49,000 in 2015. Many
new treatment methods have been developed during recent decades. The Japanese …
new treatment methods have been developed during recent decades. The Japanese …
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
…, S Tanaka, Y Ito, Y Ajioka, T Hamaguchi… - International journal of …, 2012 - Springer
… for patients with T stage clinically diagnosed as “invasion depth cSS/cA or deeper or cN-positive;”
postoperative radiotherapy is indicated for patients with T stage pathologically …
postoperative radiotherapy is indicated for patients with T stage pathologically …
[HTML][HTML] Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
…, S Tanaka, Y Ito, Y Ajioka, T Hamaguchi… - International journal of …, 2015 - Springer
Colorectal cancer is a major cause of death in Japan, where it accounts for the largest number
of deaths from malignant neoplasms among women and the third largest number among …
of deaths from malignant neoplasms among women and the third largest number among …
[HTML][HTML] NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel
T Hamaguchi, Y Matsumura, M Suzuki… - British journal of …, 2005 - nature.com
… The statistical significance of the differences in neurotoxic activity between two administration
groups was calculated using the Student's t-test on the closed testing procedure. The …
groups was calculated using the Student's t-test on the closed testing procedure. The …
[HTML][HTML] A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation
T Hamaguchi, K Kato, H Yasui, C Morizane… - British journal of …, 2007 - nature.com
This phase I study was designed to examine the maximum tolerated dose (MTD), the dose-limiting
toxicities (DLTs), the recommended dose (RD) for phase II, and the pharmacokinetics …
toxicities (DLTs), the recommended dose (RD) for phase II, and the pharmacokinetics …